ahlam1399
09-23-2015, 03:50 PM
OncoGenex Pharma?s cancer drug **t effective in study
Sept 23 (Reuters) - Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was **t effective in a mid-stage study.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a188549/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sUVqXlI0whk:EgnmJHXs0vs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sUVqXlI0whk:EgnmJHXs0vs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/sUVqXlI0whk
Sept 23 (Reuters) - Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was **t effective in a mid-stage study.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a188549/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sUVqXlI0whk:EgnmJHXs0vs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sUVqXlI0whk:EgnmJHXs0vs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=sUVqXlI0whk:EgnmJHXs0vs:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/sUVqXlI0whk